|
Andrew Schiff, MD, MBA joined Aisling Capital in September of 1999 and currently serves as a Managing Director. Prior to that, he practiced internal medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of Medicine. He currently serves as a director of Adams Respiratory Therapeutics, Inc., ArgiNOx Pharmaceuticals, Inc., Bioenvision, Inc., CardioKine, Inc., and SkinMedica, Inc. Dr. Schiff received his M.D. from Cornell University Medical College and his M.B.A. from Columbia University. His bachelor's degree in neuroscience was awarded with honors by Brown University. | 